Pelthos Therapeutics, Inc. (PTHS)
24.73
-0.27
(-1.08%)
USD |
NYAM |
Aug 28, 16:00
24.46
-0.27
(-1.09%)
After-Hours: 20:00
Pelthos Therapeutics 1 Year Total Returns (Daily) : 7.57% for Aug. 28, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 28, 2026 | 7.57% |
| August 27, 2026 | 5.40% |
| August 26, 2026 | 17.79% |
| August 25, 2026 | 20.41% |
| August 24, 2026 | 18.31% |
| August 21, 2026 | 18.93% |
| August 20, 2026 | 24.52% |
| August 19, 2026 | 25.89% |
| August 18, 2026 | 22.81% |
| August 17, 2026 | 23.57% |
| August 14, 2026 | 45.04% |
| August 13, 2026 | 59.24% |
| August 12, 2026 | 52.16% |
| August 11, 2026 | 50.68% |
| August 10, 2026 | 52.31% |
| August 07, 2026 | 42.30% |
| August 06, 2026 | 47.10% |
| August 05, 2026 | 35.90% |
| August 04, 2026 | 27.14% |
| August 03, 2026 | 28.70% |
| July 31, 2026 | 35.51% |
| July 30, 2026 | 20.47% |
| July 29, 2026 | 16.95% |
| July 28, 2026 | 25.43% |
| July 27, 2026 | 25.47% |
| Date | Value |
|---|---|
| July 24, 2026 | 17.82% |
| July 23, 2026 | 29.86% |
| July 22, 2026 | 29.12% |
| July 21, 2026 | 35.38% |
| July 20, 2026 | 34.29% |
| July 17, 2026 | 21.96% |
| July 16, 2026 | 32.39% |
| July 15, 2026 | 28.73% |
| July 14, 2026 | 19.08% |
| July 13, 2026 | 43.29% |
| July 10, 2026 | 0.26% |
| July 09, 2026 | 64.91% |
| July 08, 2026 | 40.85% |
| July 07, 2026 | -5.20% |
| July 06, 2026 | 50.32% |
| July 02, 2026 | 56.18% |
| July 01, 2026 | 107.4% |
| June 30, 2026 | 124.3% |
| June 29, 2026 | 104.1% |
| June 26, 2026 | 148.1% |
| June 25, 2026 | 147.5% |
| June 24, 2026 | 144.3% |
| June 23, 2026 | 152.1% |
| June 22, 2026 | 154.6% |
| June 18, 2026 | 141.7% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Travere Therapeutics, Inc. | 271.0% |
| ACADIA Pharmaceuticals, Inc. | 10.98% |
| Alnylam Pharmaceuticals, Inc. | -47.58% |
| Anika Therapeutics, Inc. | 128.6% |
| Savara, Inc. | 60.86% |